| Financial Ratios | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Return on Equity | -45.119 | - | - | - |
| Net Profit Margin | -211.755 | 132.435 | -145.959 | -68.979 |
| Debt to Asset Ratio | 35.434 | - | - | - |
| Cash Ratio | 128.884 | - | - | - |
| Quick Ratio | 197.249 | - | - | - |
| Current Ratio | 277.024 | - | - | - |
ReShape Lifesciences Inc. (RSLS)
ReShape Lifesciences Inc. (RSLS)